MedTrace Logo

Surveillance of HCV in Uremics and Linking to Medical Care

NCT03803410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2973

Last updated 2022-06-01

No results posted yet for this study

Summary

HCV remains to prevail in the uremic patients under hemodialysis. The comprehensive surveillance in the risk population facilitates the link to care for HCV eradication.

Conditions

  • Hepatitis C

Interventions

PROCEDURE

blood test, noninvasive test for liver fibrosis

blood test of HCV serology and virology.noninvasive test including M2BPGi and fibroscan for liver fibrosis

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Ming-Lung Yu, MD.,PhD. · Kaohsiung Medical University

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-07
Primary Completion
2022-05-20
Completion
2022-05-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803410 on ClinicalTrials.gov